<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>77(4)</volume><submitter>Andiappan AK</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NCATS NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>Agency for Science, Technology and Research</funding><funding>National Medical Research Council</funding><journal>Allergy</journal><pagination>1297-1299</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8960346</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease.</pubmed_title><pmcid>PMC8960346</pmcid><funding_grant_id>202D800012</funding_grant_id><funding_grant_id>R21 AI146804</funding_grant_id><funding_grant_id>KL2 TR001071</funding_grant_id><funding_grant_id>OFYIRG17nov065</funding_grant_id><funding_grant_id>5KL2TR001071</funding_grant_id><funding_grant_id>R21AI146804</funding_grant_id><pubmed_authors>Duan K</pubmed_authors><pubmed_authors>Jerschow E</pubmed_authors><pubmed_authors>Ren Z</pubmed_authors><pubmed_authors>Sehanobish E</pubmed_authors><pubmed_authors>Akbar N</pubmed_authors><pubmed_authors>Lum J</pubmed_authors><pubmed_authors>Chan XY</pubmed_authors><pubmed_authors>Gibber M</pubmed_authors><pubmed_authors>Rotzschke O</pubmed_authors><pubmed_authors>Asad M</pubmed_authors><pubmed_authors>Ang N</pubmed_authors><pubmed_authors>Chua C</pubmed_authors><pubmed_authors>Lee B</pubmed_authors><pubmed_authors>Howland S</pubmed_authors><pubmed_authors>Abuzeid WM</pubmed_authors><pubmed_authors>Gersten A</pubmed_authors><pubmed_authors>Porcelli SA</pubmed_authors><pubmed_authors>Andiappan AK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease.</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-22T11:52:00.416Z</modification><creation>2025-04-06T00:05:36.743Z</creation></dates><accession>S-EPMC8960346</accession><cross_references><pubmed>34921681</pubmed><doi>10.1111/all.15198</doi></cross_references></HashMap>